Tag: PROMISE I

LimFlow raises US$40 millions in Series D financing

LimFlow recently announced it has closed a US$40 million (€36 million) oversubscribed Series D financing round. A press release reports that new investors Longitude...

One-year outcomes from PROMISE I US study of LimFlow system published

LimFlow SA recently announced the publication of 12-month data from the full patient cohort in its PROMISE I study of the LimFlow percutaneous deep...

PROMISE I: LimFlow system enables vast majority of patients to avoid...

LimFlow SA has announced the presentation of one-year data from the full patient cohort in its PROMISE I study of the LimFlow percutaneous deep...

VIVA 2019: LimFlow announces positive six-month data From PROMISE I US...

LimFlow SA today announced the presentation of positive six-month data from the full patient cohort in its PROMISE I early feasibility study of the...